HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CY 208-243

structure given in first source
Also Known As:
4,6,6a,7,8,12b-hexahydro-7-methylindolo(4,3-ab)-phenanthridine; CY-208-243; indolophenanthridine; Indolo(4,3-ab)phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, trans-(-)-
Networked: 15 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wisniecki, Ania: 1 article (01/2005)
2. Salamone, John D: 1 article (01/2005)
3. Rios, Clifford: 1 article (01/2005)
4. Lentini, Elizabeth: 1 article (01/2005)
5. Betz, Adrienne: 1 article (01/2005)
6. Correa, Merce: 1 article (01/2005)
7. Carlson, Brian B: 1 article (01/2005)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Tremor (Tremors)
3. Dyskinesias (Dyskinesia)
4. Parkinsonian Disorders (Parkinsonism)
5. Seizures (Seizure)

Related Drugs and Biologics

1. Dopamine Agonists (Dopamine Agonist)
2. 2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)
3. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
4. Pilocarpine (Ocusert)
5. Levodopa (L Dopa)
6. Dopamine (Intropin)
7. 4,4a,5,6,7,8,8a,9- octahydro- 5- propyl- 1H- pyrzolo(3,4- g)quinoline
8. Dopamine D2 Receptors (Dopamine D2 Receptor)
9. Dopamine D1 Receptors (Dopamine D1 Receptor)
10. Antipsychotic Agents (Antipsychotics)

Related Therapies and Procedures

1. Denervation